Lorcaserin Extended-Release Tablets and Orthoclone OKT 3
Determining the interaction of Lorcaserin Extended-Release Tablets and Orthoclone OKT 3 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: muromonab-cd3
Brand name:
Synonyms: Orthoclone OKT 3 (Intravenous), Orthoclone OKT3
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Orthovisc
- Lorcaserin Extended-Release Tablets-Orudis
- Lorcaserin Extended-Release Tablets-Orudis KT
- Lorcaserin Extended-Release Tablets-Oruvail
- Lorcaserin Extended-Release Tablets-Orvaten
- Lorcaserin Extended-Release Tablets-Os-Cal 500+D
- Orthoclone OKT 3-Lorcaserin Hydrochloride
- Orthoclone OKT 3-Lorcaserin Tablets
- Orthoclone OKT 3-Lorcet
- Orthoclone OKT 3-Lorcet Plus
- Orthoclone OKT 3-Lorcet Tablets
- Orthoclone OKT 3-Lorlatinib